article thumbnail

X-trodes Receives FDA 510(k) Clearance for Wearable "Skin" Solution that Brings Medical-Grade Electrophysiological Monitoring to the Home

DAIC

Food and Drug Administration ( FDA ) has granted 510(k) clearance for X-trodes' Smart Skin solution (marketed as X-trodes System M), a new wireless wearable technology for advanced electrophysiological monitoring. X-trodes' technology is backed by more than 15 years of research at Prof.

article thumbnail

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

DAIC

The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. Gery Tomassoni , Director of Electrophysiology at Baptist Health Lexington.

article thumbnail

First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology

DAIC

Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. As electrophysiologists, our primary goal is to improve the lives of our patients,” said Dr. Mario Volpicelli , Head of the Electrophysiology Unit of the hospital. added Giuseppe Russo, General Manager of the Hospital Santa Maria della Pietà. “We

article thumbnail

HCA hospital 1st to use new tech in electrophysiology lab

Becker's Hospital Review - Cardiology

Davie-based HCA Florida University Hospital opened a new electrophysiology lab and is the first in the country to use new technology in the lab, it said in a May 30 news release.

article thumbnail

HRS 2024: Innovation Meets Reality

DAIC

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.

article thumbnail

How AI-Powered ECG Analysis is Advancing Cardiometabolic Research: Our Latest Study with University Hospital Basel

Cardiomatics

A key focus of the research was heart rate variability (HRV)analyzed using our AI-powered ECG technology. Our work spans cardiac electrophysiology, metabolic research, and AI-driven ECG analysis. These commonly used anti-inflammatory drugs often cause insulin resistance, high cholesterol, and muscle loss.

article thumbnail

CardioVia Receives FDA Clearance for Minimally Invasive Heart-Surface Treatment

DAIC

David Luria (left), Director of Electrophysiology at Hadassah Medical Center, and Ziv Menshes (right), CEO of CardioVia tim.hodson Tue, 04/08/2025 - 14:38 April 7, 2025 CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S. Food and Drug Administration (FDA) clearance for its ViaOne system.